Related Experiment Video
Updated: Dec 4, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.8K
Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment
Kekoa Taparra1,2,3, Scott C Lester1, W Scott Harmsen4,3
1Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
International Journal of Particle Therapy
|October 23, 2020
Summary
Intensity modulated proton therapy (IMPT) significantly reduces radiation dose to the heart and lungs in patients with mediastinal lymphoma compared to intensity modulated radiation therapy (IMRT). This cardiac substructure sparing (CSS) optimization may lead to improved clinical outcomes.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cardiology
Background:
- Intensity modulated radiation therapy (IMRT) with cardiac substructure sparing (CSS) optimization aims to reduce radiation dose to cardiac substructures.
- Electrocardiogram-gated computed tomography angiography is utilized for precise treatment planning in IMRT.
- Mediastinal lymphoma patients are at risk of cardiac toxicity due to radiation therapy.
Purpose of the Study:
- To investigate if intensity modulated proton therapy (IMPT) can further reduce radiation dose to cardiac substructures compared to IMRT in mediastinal lymphoma patients.
- To evaluate the effectiveness of IMPT in cardiac substructure sparing (CSS) optimization.
Main Methods:
- Twenty-one patients with mediastinal lymphoma underwent electrocardiogram-gated computed tomography angiography for radiotherapy planning.
- Comparative treatment planning was performed using both IMPT and IMRT for 13 patients with delineated cardiac substructures.
- Plans were normalized for equivalent 95% target volume coverage to ensure a fair comparison.
Main Results:
- IMPT-CSS significantly reduced mean dose to all cardiac substructures, including coronary arteries and cardiac valves, compared to IMRT-CSS.
- Average whole-heart dose was reduced from 9.6 Gy to 4.9 Gy with IMPT (P < .0001).
- Clinically meaningful improvements were observed in coronary arteries (69%), cardiac valves (77%), and the whole heart (100%) with IMPT.
Conclusions:
- IMPT-CSS treatment planning significantly reduces radiation dose to cardiac substructures in patients with mediastinal lymphoma.
- The observed dose reductions suggest potential for improved clinical outcomes, aligning with previous CSS optimization analyses.
- IMPT represents a promising advancement for reducing cardiac toxicity in mediastinal lymphoma radiotherapy.

